PetMed Express (PETS): Puppy profits?

Filed under: Newsletters, Stocks to Buy

"One way to deal with a choppy market is to focus on steady performers with strong market positions in growing industries," says Richard Moroney.

In his Upside Stocks, a leading newsletter focused on small and mid-cap stocks,, he notes, "PetMed Express (NASDAQ: PETS), a leading nationwide pet pharmacy and retailer, fits the bill nicely." Here, the advisor offers his review.

"PetMed Express sells prescription (30% of fiscal 2007 revenue) and nonprescription medications and health products (70%) to retail customers ordering by phone, via the Internet, or through a catalog. The company's Web site generates nearly two-thirds of annual sales.

"Fiscal 2008 ending March should represent the firm's sixth consecutive year of at least 20% per-share profit growth. While earnings growth is expected to slow to about 10% in fiscal 2009, recent operating results suggest PetMed is capable of exceeding consensus expectations.

"PetMed is benefiting from strong market fundamentals and constructive trends. An estimated 63% of U.S. households own a pet, up from 56% in 1988. The U.S. dog and cat population is estimated at a staggering 163 million.

Continue reading PetMed Express (PETS): Puppy profits?

<map name="google_ad_map_145-1157517"><area href="http://imageads.googleadservices.com/pagead/imgclick/145-1157517?pos=0" shape="rect" coords="1,2,367,28" /><area href="http://services.google.com/feedback/abg" shape="rect" coords="384,10,453,23" /></map>